164 completed, 50 terminated, 40 unknown, 13 withdrawn. 289 Phase 3, 63 Phase 2.
Follow Diabetes Complications: new trials by email Literature Review of Diabetes Complications trials Research Report on Diabetes Complications
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-02) OLN324, Aflibercept - Diabetic Macular Edema (DME) | Phase 3 | Not yet recruiting | Ollin Biosciences, Inc. | 450 | 2026-10-15 | 2026-09-25 |
| Phase 3 Study of Intravitreal OLN324 in Adults With Diabetic Macular Edema (DME) (OLN324-CP-03) OLN324, Aflibercept - Diabetic Macular Edema (DME) | Phase 3 | Not yet recruiting | Ollin Biosciences, Inc. | 450 | 2026-10-15 | 2026-09-25 |
| a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers Standard of Care, BIOxHEAL (human amniotic membrane allograft) - Diabetic Foot Ulcer, Amniotic Membrane Placental Allograft | Phase 3 | Recruiting | Applied Biologics, LLC | 253 | 2026-10-08 | 2026-10-16 |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005) MK-8748, Aflibercept - Diabetic Retinopathy, Macular Edema | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 1104 | 2026-09-25 | 2026-11-12 |
| Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin Fixed-dose combination of SGLT2 inhibitor and thiazolidinedione, Control Group 1 Intervention - SGLT2 inhibitor monotherapy, Control Group 2 Intervention - Thiazolidinedione monotherapy - Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-09-01 | 2025-12-18 | |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) MK-8748, Aflibercept - Diabetic Retinopathy, Macular Edema | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 960 | 2026-08-27 | 2026-11-12 |
| Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia Experimental: Pregabalin XR, Comparator: Dorene Tabs, Comparator placebo - Diabetic Neuropathy, Neuropathic Pain | Phase 3 | Recruiting | Brainfarma Industria Química e Farmacêutica S/A | 348 | 2026-06-18 | 2026-07-20 |
| Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Hua Yu Wan Capsule, Aspirin - Peripheral Arterial Disease, Diabetic Angiopathies | Phase 3 | Not yet recruiting | Xuanwu Hospital, Beijing | 300 | 2026-06-01 | 2026-06-22 |
| Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema Surabgene Lomparvovec, Sham, Topical Steroid - Diabetic Retinopathy | Phase 2 / Phase 3 | Recruiting | AbbVie | 576 | 2026-06-01 | 2026-10-29 |
| "Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes" Dapagliflozin +Finerenone arm, Dapagliflozin arm - Diabetic Nephropathy | Phase 3 | Not yet recruiting | Chittagong Medical College | 88 | 2026-05-01 | 2026-05-20 |
| Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients Semaglutide, 1.34 mg/mL, Placebo - Foot Ulcer Due to Type 2 Diabetes Mellitus | Phase 3 | Recruiting | Ole Lander Svendsen | 52 | 2026-04-24 | 2026-05-12 |
| Phase IIb and III Safety and Efficacy Study Chlorin E6 Gel Photodynamic Therapy for Diabetic Foot Ulcers: Chlorin E6 Gel - Diabetic Foot Ulcer (DFU) | Phase 3 | Recruiting | United Medical and Dental College | 300 | 2026-04-02 | 2026-04-07 |
| The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy DLBS1033, Placebo Comparator: Placebo + Standard Therapy - Diabetic Polyneuropathy, Peripheral Nervous System Diseases | Phase 2 / Phase 3 | Not yet recruiting | Universitas Sebelas Maret | 34 | 2026-03-01 | 2026-03-16 |
| Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds Amniotic Tissue Allograft - Chronic Wounds, Venous Leg Ulcers (VLUs) | Phase 3 | Not yet recruiting | Bardia Anvar | 600 | 2026-01-01 | 2025-11-06 |
| REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis Reamberin, Placebo - Diabetic Ketoacidosis | Phase 2 / Phase 3 | Recruiting | POLYSAN Scientific & Technological Pharmaceutical Company | 312 | 2025-05-01 | 2025-06-24 |
| The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers Bromelain, Placebo - Diabetic Foot Ulcer (DFU) | Phase 3 | Not yet recruiting | Dr Azita Hekmatdoost | 70 | 2025-03-01 | 2025-01-22 |
| Tailored Exercise Training Study Among Adults With HFpEF Moderate-intensity continuous training (MCT), Resistance training, Weight loss - HFpEF - Heart Failure With Preserved Ejection Fraction, Diabetic Cardiomyopathies | Phase 2 / Phase 3 | Recruiting | University of Texas Southwestern Medical Center | 120 | 2025-02-18 | 2025-10-31 |
| SGLT2 Adjunct in T1D Empagliflozin (EMPA), Placebo - Type 1 Diabetes, Nephropathy, Diabetic | Phase 2 / Phase 3 | Completed | Ain Shams University | 86 | 2024-11-20 | 2026-05-18 |
| Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease Sotagliflozin, Placebo - Diabetic Nephropathies, Kidney Failure, Chronic | Phase 3 | Recruiting | Alessandro Doria | 150 | 2024-10-31 | 2026-03-24 |
| Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers Xianglei Tangzu Gao, Vehicle Cream - Diabetic Foot Ulcer | Phase 2 / Phase 3 | Active not recruiting | Oneness Biotech Co., Ltd. | 120 | 2024-08-16 | 2026-06-12 |
Showing 20 of 289. Sign in to see all of them.
Diabetic Neuropathies (76) · Diabetic Foot (73) · Diabetic Retinopathy (70) · Diabetes Mellitus (57) · Diabetic Nephropathies (55) · Diabetes Mellitus, Type 2 (27) · Macular Edema (17) · Pain (16) · Neuralgia (13) · Diabetes Mellitus, Type 1 (11) · Kidney Diseases (11) · Peripheral Nervous System Diseases (11) · Ulcer (10) · Hypoglycemia (9)
Endocrine System Diseases (289) · Diabetes Mellitus (232) · Cardiovascular Diseases (152) · Vascular Diseases (150) · Diabetic Angiopathies (142) · Nutritional and Metabolic Diseases (97) · Metabolic Diseases (96) · Glucose Metabolism Disorders (93) · Nervous System Diseases (88) · Pathological Conditions, Signs and Symptoms (79) · Neuromuscular Diseases (76) · Skin Diseases (73) · Skin and Connective Tissue Diseases (73) · Leg Ulcer (72)
Standard of Care (14) · aflibercept (12) · Insulin Aspart (10) · Pregabalin (10) · Ranibizumab (10) · Bevacizumab (9) · salicylhydroxamic acid (7) · Duloxetine Hydrochloride (6) · Insulin, Regular, Human (6) · 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)- (5) · Triamcinolone Acetonide (5) · Fenofibrate (4) · Lacosamide (4) · Microspheres (4) · Octreotide (4)
Florida Atlantic University (10) · Eli Lilly and Company (8) · UCB Pharma (7) · Jaeb Center for Health Research (6) · National Eye Institute (NEI) (6) · Novartis Pharmaceuticals (6) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (6) · Pfizer (5) · Bayer (4) · Chromaderm, Inc. (4) · Helixmith Co., Ltd. (4) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4) · Kodiak Sciences Inc (4) · Tanta University (4) · Wyeth is now a wholly owned subsidiary of Pfizer (4)
United States (110) · Germany (35) · Canada (30) · Spain (27) · United Kingdom (27) · Italy (22) · Australia (20) · Poland (20) · China (18) · France (18) · Denmark (17) · Hungary (17) · Mexico (17) · Netherlands (16) · Puerto Rico (16)
Betty Tuller, PhD (6) · Pablo Velazquez-Martin, MD (4) · Betty Tuller, Ph.D (3) · Karl Beutner (3) · Hugo Quiroz-Mercado, MD (2) · Jean-Charles Kerihuel, MD (2) · Lisa R Grillone, PhD (2)
PMID 33107592, PMID 37872654, PMID 40526444, PMID 18441312, PMID 18990064, PMID 20008710, PMID 20427088, PMID 21571677, PMID 22999634, PMID 25018648, PMID 25439614, PMID 26802783, PMID 27611736, PMID 30084288, PMID 30206821, PMID 30521533, PMID 31802967, PMID 33280027, PMID 33358451, PMID 36251465, PMID 36287567, PMID 36328655, PMID 36639130, PMID 36864892, PMID 36927680, PMID 37745646, PMID 38046911, PMID 38048573, PMID 38508632, PMID 38682786, PMID 38770818, PMID 39380152, PMID 40315020, PMID 40892478, PMID 41196655, PMID 41198855, PMID 41289823, PMID 41533467, PMID 41679125, PMID 41827014, PMID 42234437, PMID 11128345, PMID 12766097, PMID 15504999, PMID 15834546, PMID 17065669, PMID 17257476, PMID 17327325, PMID 17327338, PMID 17563333
2015 (4), U10EY014231 (3), 2004 (2), 2005 (2), 2009 (2), U10EY014229 (2), U10EY018817 (2), 1KL2RR025015-01 (1), 2014 (1), 2017 (1), 2019 (1), 2023 (1), N01HC095178 (1), P30DK017047 (1), R01DK047112 (1)